Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05233891

Validation of Scales in Reconstructive Breast Surgery

The main purpose of the project is to validate patient reported outcomes measures (PROMs) in reconstructive breast surgery. BREAST-Q will be evaluated for Swedish and Sweden.Hospital Anxiety and Depression Scale (HADS), EuroQol 5D (EQ5D), and SF-36 will be validated for reconstructive breast surgery. In addition, the complication classification system according to Clavien-Dindo will be validated for reconstructive breast surgery.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–100 year

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women who have had or will have reconstructive breast surgery in Sahlgrenska university hospital.

Exclusion criteria

  • Do not understand Swedish.

Treatment and study plan

Breast reconstruction

Procedure

Breast reconstruction after breast cancer.

Breast reduction

Procedure

Breast reduction due to breast hypertrophy.

Other names: mammoplasty reduction

Primary outcomes

  1. Validation and reliability of BREAST-Q for Sweden

    Time frame: Pre-operatively

    Breast-Q measures breast related quality of life on a scale 1-100. A higher score indicates a higher quality of life.

  2. Validation and reliability of BREAST-Q for Sweden

    Time frame: 5 years postoperatively

    Breast-Q measures breast related quality of life on a scale 1-100. A higher score indicates a higher quality of life.

  3. Validation and reliability of EuroQol-5 dimensions, 3 levels for reconstructive breast surgery

    Time frame: Pre-operatively

    EuroQol-5 dimensions-3 levels (EQ5D) is a generic instrument developed for health economic and clinical evaluation of healthcare. A total score between 0 and 1 is calculated. Zero equals death and 1 perfect health.

  4. Validation and reliability of EuroQol-5 dimensions, 3 levels for reconstructive breast surgery

    Time frame: 5 years postoperatively

    EuroQol-5 dimensions-3 levels (EQ5D) is a generic instrument developed for health economic and clinical evaluation of healthcare. A total score between 0 and 1 is calculated. Zero equals death and 1 perfect health.

  5. Validation and reliability of Hospital Anxiety and Depression scale (HADS) for Reconstructive breast surgery

    Time frame: Pre-operatively

    The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).

  6. Validation and reliability of Hospital Anxiety and Depression scale (HADS) for Reconstructive breast surgery

    Time frame: 5 years postoperatively

    The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).

  7. Validation and reliability of RAND-36 for reconstructive breast surgery

    Time frame: Pre-operatively

    It comprises eight subdomains: physical functioning (10 items), role limitations caused by physical health problems (4 items), role limitations caused by emotional problems (3 items), social functioning (2 items), emotional well-being (5 items), energy/fatigue (4 items), pain (2 items), and general health perceptions (5 items) where patients score their health during the last four weeks on Likert scales. Every item score is transformed linearly to the per cent of total possible score (0-100) and then averaged by the values of the scale. A subscore is calculated for each domain and in addition two summary scores, physical and mental health, are calculated.

  8. Validation and reliability of RAND-36 for reconstructive breast surgery

    Time frame: 5 years postoperatively

    It comprises eight subdomains: physical functioning (10 items), role limitations caused by physical health problems (4 items), role limitations caused by emotional problems (3 items), social functioning (2 items), emotional well-being (5 items), energy/fatigue (4 items), pain (2 items), and general health perceptions (5 items) where patients score their health during the last four weeks on Likert scales. Every item score is transformed linearly to the per cent of total possible score (0-100) and then averaged by the values of the scale. A subscore is calculated for each domain and in addition two summary scores, physical and mental health, are calculated.

  9. Validation of Clavion-Dindo classification for reconstructive breast surgery

    Time frame: 5 years postoperatively

    The Clavien-Dindo system is based on ranking the severity of the intervention required to treat a given complication, as follows: grade I includes deviations from the postoperative course without the need for pharmacological treatment or surgical/endoscopic/radiological intervention; grade II complications require pharmacological treatment, blood transfusion, or total parental nutrition; grade III complications require surgical/endoscopic/radiological intervention; grade IV includes life-threatening complications, including those involving the central nervous system, that require intensive care treatment; and grade V includes complications that result in death.

Study contacts

Contact information is provided by the study sponsor or research team.

Emma Hansson, MD, PhD

CONTACT

[email protected]

+46313421000

Sponsors and collaborators

Lead sponsor

Vastra Gotaland Region

Other Gov

Registry information

Acronym: ValPlast

Important dates

Study start
2021
Primary completion
2027
Study completion
2027
First posted
Feb 10, 2022
Registry last updated
Jul 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.